INSILICO MEDICINE
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digita... l medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.
INSILICO MEDICINE
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Hong Kong, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.insilico.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
401.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro COVID-19
Similar Organizations
3billion
3billion is a world leader in the field of genetic diagnostics for rare disease.
![]()
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
![]()
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
![]()
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
![]()
![]()
Current Employees Featured
![]()
![]()
![]()

![]()
Founder
![]()
Investors List
![]()
B Capital Group
B Capital Group investment in Series D - Insilico Medicine
BHR Partners
BHR Partners investment in Series D - Insilico Medicine
Prosperity7 Ventures
Prosperity7 Ventures investment in Series D - Insilico Medicine
![]()
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati investment in Series D - Insilico Medicine
![]()
Deerfield
Deerfield investment in Series D - Insilico Medicine
![]()
Pavilion Capital
Pavilion Capital investment in Series D - Insilico Medicine
![]()
Warburg Pincus
Warburg Pincus investment in Series D - Insilico Medicine
![]()
Qiming Venture Partners
Qiming Venture Partners investment in Series D - Insilico Medicine
![]()
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
![]()
Bold Capital Partners
Bold Capital Partners investment in Series D - Insilico Medicine
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.insilico.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.88 K
- Host name: 185.215.4.66
- IP address: 185.215.4.66
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
